International Review of Cell and Molecular Biology

Lorenzo Galluzzi (Redaktør)

International Review of Cell and Molecular Biology, Volume 354 reviews and details current advances in cell and molecular biology. The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists. Les mer
Vår pris
2785,-

(Innbundet) Fri frakt!
Leveringstid: Sendes innen 21 dager

Innbundet
Legg i
Innbundet
Legg i
Vår pris: 2785,-

(Innbundet) Fri frakt!
Leveringstid: Sendes innen 21 dager

Om boka

International Review of Cell and Molecular Biology, Volume 354 reviews and details current advances in cell and molecular biology. The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists. Sections in this new release include P73 in health and disease, The biology of LONP1, Molecular mechanisms of selective autophagy in Drosophila, Metabolic reprogramming and cisplatin resistance, The biology of polycystin 2, Pharmacological methods to transcriptionally modulate double-strand break DNA repair, Evolutionary insights into the aphid genome, Stratifying nutritional interventions in cancer therapy: next stop, personalized medicine, Vascular calcifications in health and disease

Fakta

Innholdsfortegnelse

1. The biology of Lonp1: More than a mitochondrial protease

Lara Gibellini, Anna De Gaetano, Mauro Mandrioli, Elia Van Tongeren, Carlo Augusto Bortolotti, Andrea Cossarizza and Marcello Pinti

2. Molecular mechanisms of selective autophagy in Drosophila

Raksha Gohel, Athanasios Kournoutis, Stavroula Petridi and Ioannis P. Nezis

3. Links between cancer metabolism and cisplatin resistance

Veronica Cocetta, Eugenio Ragazzi and Monica Montopoli

4. New emerging roles of Polycystin-2 in the regulation of autophagy

Daniel Peña-Oyarzun, Ana Batista-Gonzalez, Catalina Kretschmar, Paulina Burgos, Sergio Lavandero, Eugenia Morselli and Alfredo Criollo

5. Pharmacological methods to transcriptionally modulate double-strand break DNA repair

Alanna R. Kaplan and Peter M. Glazer

6. Evolutionary insights into the aphid genome: Aphid genomics between quality problems and intriguing perspectives

Mauro Mandrioli and Gian Carlo Manicardi

7. Stratifying nutritional restriction in cancer therapy: Next stop, personalized medicine

Jelena Krstic, Thomas R. Pieber and Andreas Prokesch

8. The biology of vascular calcification

Quaglino Daniela, Boraldi Federica and Lofaro Francesco Demetrio

Om forfatteren

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.

Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.